Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...

Aminoglycosides are antibiotics effective against a wide range of bacteria such as Escherichia coli, Pseudomonas aeruginosa ...

Wockhardt shares surge as US FDA accepts first-ever NDA from an Indian pharma company for new antibiotic Zaynich, aimed at ...

Researchers have designed a chemical phototherapy tool that when exposed to blue light damages an enzyme found in ...

Stool-based tests that combine microbial markers such as Fusobacterium nucleatum, colibactin-positive E. coli and ...

Researchers employed a technique that can allow the discovery of novel microbiome-produced metabolites not seen under standard laboratory conditions.

The study analyzed a specific sample of used products that were collected from Virginia schools between 2024 and 2025.

Zaynich targets complicated urinary tract infections (cUTIs) caused by multi-drug resistant (MDR) gram-negative bacteria.

India expands lab and surveillance networks to fight rising antimicrobial resistance, as experts warn of growing drug-resistant infections and call for stronger stewardship and coordinated global ...

Dr Muniruddin Ahmed.On October 13, The Guardian published an alarming report titled ‘Sharp global rise in ...

A new experimental antibiotic has stunned researchers by wiping out dangerous bacteria at concentrations roughly two orders ...